GUNA Webinars

2 February 2017

2017 Educational Webinar Series begins

Tuesday, February 21, 2017

8 P.M. EST/ 5 P.M. PST


Inflammation and Low Dose Medicine for the treatment of acute, chronic, and autoimmune inflammatory diseases

Understanding the deep mechanisms of inflammation is the key to  effectively manage this physio-pathologic process  at the base of a huge number of diseases.

To provide a novel pharmacological approach to inflammatory diseases, GUNA Biotherapeutics, in conjunction with world-class experts in immunology and leading academic research institutions have combined their efforts to develop innovative and advanced low dose therapies supported by clinical studies.

 

Why attend?


In the 70s, inflammation has been studied mainly as pathological process, investigating above all the biochemical mechanisms and using medications able to act on symptoms only. In the 80s-90s it has been studied as immunological process, the new millennium allowed us to know the neuro-immune-endcrine mechanisms that control the trigger, the development and the resolution of the complex pathways of inflammation.

Starting from this knowledge, a new pharmacological approach can be used for treating different type of inflammatory diseases and a big number of pre-clinical and clinical evidence shows the efficacy of GUNA medications in the management of these diseases.

What will you learn?


Efficacy and no side effects are the targets of Physiological Regulating Medicine. Recent studies show that these targets can be reached using low dose cytokines used by themselves or in combination with natural, homeopathic substances. Starting with this evidences, the speaker will focus on how GUNA medications, thanks to their unique composition, are able to act on all the phases of inflammation from the beginning to the resolution. A consistent part of the webinar will be dedicated to the presentation of protocols coming from the research. You will have a deeper understanding of the immunological action mechanism of each interleukin involved in inflammation and will learn WHY and HOW they work and HOW to prescribe them to your patients.
 

Check back soon!

Registration opens Wednesday, February 8, 2017